6,7-dihydroxy-3-phenyl-2H-chromen-2-one | 20759-62-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 6,7-dihydroxy-3-phenyl-2H-chromen-2-one
• 英文别名: 6,7-Dihydroxy-3-phenyl-cumarin；6,7-dihydroxy-3-phenylcoumarin；6,7-dihydroxy-3-phenyl-chromen-2-one；6,7-Dihydroxy-3-phenylchromen-2-one
• CAS: 20759-62-0
• 化学式: C₁₅H₁₀O₄
• 分子量: 254.242
• InChiKey: WWTFLYLWPWKBJR-UHFFFAOYSA-N

物化性质

• 熔点：
  242 °C
• 沸点：
  536.9±50.0 °C(Predicted)
• 密度：
  1.443±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6,7-dihydroxy-3-phenyl-2H-chromen-2-one 生成 6,7-diacetoxy-3-phenyl-coumarin
  参考文献：
  名称：

  355.α-甲酰基苯基乙腈与酚的缩合。第二部分

  摘要：

  DOI：

  10.1039/jr9320002420
• 作为产物：
  描述：

  6,7-diacetoxy-3-phenyl-coumarin 在 氨 作用下， 以 乙醇 为溶剂， 反应 12.0h， 以30.1%的产率得到6,7-dihydroxy-3-phenyl-2H-chromen-2-one
  参考文献：
  名称：

  Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents

  摘要：

  Based on the observed biological activities of coumarins and resveratrol, we synthesized fourteen hydroxylated 3-phenylcoumarins (stilbene-coumarin hybrids) including six novel ortho-hydroxy-methoxy substituted derivatives, 1-14, by Perkin reaction. We characterized these compounds concerning their antioxidant activity against 2,2'-azobis(2-amidinopropane hydrochloride) (AAPH)-induced pBR322 DNA strand breakage, and their antiproliferative effects on human promyelocytic leukemia HL-60 and human lung adenocarcinoma epithelial A549 cells. Structure-activity relationship information suggests that the introduction of ortho-hydroxy-methoxy groups and ortho-dihydroxy groups on the aromatic A ring could efficiently improve antiproliferative activity. Interestingly, a new derivative, 6-methoxy-7-hydroxy-3-(4'-hydroxyphenyl)coumarin, 9, behaved as a poor antioxidant but appeared to be the most potent antiproliferative agent among the compounds examined, and this activity was mediated by deregulation in cell cycle and induction of apoptosis. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.08.090

文献信息

• The synthesis of novel crown ethers, part ix, 3-phenyl chromenone-crown ethers
  作者：M. Bulut、Ç L. Erk

  DOI：10.1002/jhet.5570380608

  日期：2001.11

  resolution mass spectroscopy and elemental analysis. Some 1:1 cation association constants, Kb, of the 3-phenyl chromenone crown ethers with Li+, Na+, K+ and Rb+ cations were studied by steady state emission fluorescence spectroscopy; Kb chromenone-crown complexes displayed crown ether-cation binding selectivity rules properly in acetonitrile.

  由3-氧代-2-苯基丙酸乙酯，3-氧代-2-（4-甲氧基苯基）-乙基制备3-苯基-和3-（对甲氧基苯基）-7,8-二羟基和-6,7-二羟基色酮。丙酸酯和H 2 SO 4中的三羟基苯。3-芳基-7,8-和3-芳基-6,7-二羟基-2H-色农酮与聚乙二醇的二-二卤化物在DMF / MeCO 3中反应，得到12-Crown- 4、15 -Crown-4和18-Crown-6-chromenones。产物通过IR，1 H NMR，低和高分辨率质谱法以及元素分析鉴定。3-苯基色酮冠醚与Li +，Na +，K +和Rb +的一些1：1阳离子缔合常数K b通过稳态发射荧光光谱研究阳离子。K b色酮-冠状配合物在乙腈中显示出正确的冠醚-阳离子结合选择性规则。
• Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives
  申请人：Auriol Daniel

  公开号：US20090233876A1

  公开（公告）日：2009-09-17

  The invention relates to the preparation of phenolics derivatives by enzymatic condensation of phenolics selected among pyrocatechol or its derivatives with the glucose moiety of sucrose. The production of said phenolics derivatives is achieved with a glucosyltransferase (EC 2.4.1.5). These O-α-glucosides of selected phenolics are new, have a solubility in water higher than that of their parent polyphenol and have useful applications in cosmetic and pharmaceutical compositions, such as antioxidative, antiviral, antibacterial, immune-stimulating, antiallergic, antihypertensive, antiischemic, antiarrhythmic, antithrombotic, hypocholesterolemic, antilipoperoxidant, hepatoprotective, anti-inflammatory, anticarcinogenic antimutagenic, antineoplastic, anti-thrombotic, and vasodilatory formulations, or in any other field of application.

  该发明涉及通过酶催化将选择自间苯二酚或其衍生物的酚类与蔗糖的葡萄糖部分进行缩合来制备酚类衍生物。所述酚类衍生物的生产是通过葡萄糖转移酶（EC 2.4.1.5）实现的。所选酚类的这些O-α-葡糖苷是新的，其在水中的溶解度高于它们的原始多酚，并且在化妆品和药用组合物中具有有用的应用，如抗氧化、抗病毒、抗菌、免疫刺激、抗过敏、降压、抗缺血、抗心律失常、抗血栓形成、降胆固醇、抗脂质过氧化、肝脏保护、抗炎症、抗癌变突变、抗肿瘤、抗血栓形成和扩血管等配方，或者在任何其他应用领域中。
• COUMARIN DERIVATIVE AND USE THEREOF
  申请人：MORINAGA MILK INDUSTRY CO., LTD.

  公开号：EP0645382A1

  公开（公告）日：1995-03-29

  The invention provides a compound having a 12-lipoxygenase inhibitory effect and a drug selectively inhibiting 12-lipoxygenase and relates to a novel coumarin derivative represented by general formula (1) and a drug comprising said compound as the active ingredient. In formula (1) R¹ represents hydrogen or lower alkyl; R² and R³ represent each hydrogen or hydroxyl provided that R² and R³ do not represent hydrogen atoms at the same time; and Ar represents (a) (b), (c) etc.; and R⁴ represents lower alkyl, lower alkoxy, halogen, trifluoromethyl or cyano. It further provides a compound which can be converted into another compound capable of selectively inhibiting 12-lipoxygenase activity through cleavage and breakage of its modifying moiety in vivo and a drug which selectively inhibits 12-lipoxygenase and relates to a novel coumarin derivative having an acyl group as the modifying moiety and a drug containing said compound as the active ingredient. The invention compound, which can potently inhibit 12-lipoxygenase at a high selectivity, is useful as a drug for preventing and treating circulatory diseases such as arteriosclerosis and vasoconstriction and preventing the metastasis of certain cancers. It has a low toxicity and little exhibits side effects.

  本发明提供了一种具有12-脂氧合酶抑制作用的化合物和一种选择性抑制12-脂氧合酶的药物，并涉及一种由通式(1)表示的新型香豆素衍生物和一种以上述化合物为活性成分的药物。在式(1)中，R¹代表氢或低级烷基；R²和R³分别代表氢或羟基，条件是R²和R³不同时代表氢原子；Ar代表(a)(b)、(c)等；R⁴代表低级烷基、低级烷氧基、卤素、三氟甲基或氰基。本发明进一步提供了一种化合物，该化合物可通过其修饰基团在体内的裂解和断裂转化为另一种能够选择性抑制 12-脂氧合酶活性的化合物，以及一种选择性抑制 12-脂氧合酶的药物，并涉及一种以酰基为修饰基团的新型香豆素衍生物和一种含有上述化合物作为活性成分的药物。本发明化合物能以高选择性有效抑制 12-脂氧合酶，可用作预防和治疗动脉硬化和血管收缩等循环系统疾病以及防止某些癌症转移的药物。它毒性低，副作用小。
• Phenolic compounds with cosmetic and therapeutic applications
  申请人：Libragen

  公开号：EP2027279B1

  公开（公告）日：2012-04-18
• WATER SOLUBLE AND ACTIVABLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS AND PROCESS FOR PREPARING SAID DERIVATIVES
  申请人：Libragen

  公开号：EP2027279A2

  公开（公告）日：2009-02-25